发明名称 |
Forbedret transdermalt, terapeutisk system til behandlingen af Parkinsons sygdom |
摘要 |
This invention provides the use of a silicone-based transdermal therapeutic system having an area of 10 to 40 cm<2> and containing 0.1 to 3.15 mg / cm<2> of Rotigotine as active ingredient, for the preparation of an anti-Parkinson medicament which effects an improvement, compared to a placebo treatment, of the condition of human Parkinson patients, measured according to the Unified Parkinson's Disease Rating Scale (UPDRS) parts II and III, of 2 units or more following administration for a time period of at least 7 weeks. |
申请公布号 |
DK1256340(T3) |
申请公布日期 |
2003.12.01 |
申请号 |
DK20010111110T |
申请日期 |
2001.05.08 |
申请人 |
SCHWARZ PHARMA AG;LTS LOHMANN THERAPIE-SYSTEME AG |
发明人 |
LAUTERBACH, THOMAS, DR.;SCHACHT, DIETRICH WILHELM;WOLFF, HANS-MICHAEL, DR.;MUELLER, WALTER, DR. |
分类号 |
C07D333/20;A61K9/70;A61K31/381;A61K47/30;A61K47/32;A61P25/16;(IPC1-7):A61K9/70 |
主分类号 |
C07D333/20 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|